Reducing the risk of heart attack and stroke during COVID-19 - Click here
Why focus on Atrial Fibrillation?
AF commonly causes the formation of blood clots, which increases the risk of stroke by 5 times. There are, on average, 40 AF-related strokes every day in England.
Anticoagulation is an effective therapy for managing people with AF who are at risk of stroke, and can reduce the risk of stroke by up to 66%. However, many people with AF are not on anticoagulants, meaning they are getting no treatment at all or are on ineffective treatment, such as aspirin, for AF.
Too many people are still living with undetected and poorly managed atrial fibrillation (AF) across Cheshire and Merseyside. Public Health England (PHE) and NHS England have agreed national ambitions for the detection and management of AF over the next 10 years. C&M Health and Care Partnership has committed to acheiving these ambitions through a whole-system approach.
By 2029 the AF ambitions are:
85% of the expected number of people with AF are detected
90% of people with AF who are known to be at high risk of a stroke to be adequately anticoagulated
The infographic to the right reflects national levels as at 2019.
The resources below have been collated to support partners across Cheshire and Merseyside to detect and optimally manage atrial fibrillation.
For additional resources specific to AF during the COVID-19 pandemic CLICK HERE.
(Local and National guidelines)Click here for more information
(Local and National tools)Click here for more information
(Plus links to relevant websites)Click here for more information
Includes Pharmacies that take BPs toolClick here for more information
Back to top